ELVN vs VKTX: stock comparison and AI forecast
Enliven Therapeutics, Inc. (ELVN) and Viking Therapeutics, Inc. (VKTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ELVN Enliven Therapeutics, Inc.
- Price
- $44.83 +7.8% · 6M
- Market Cap
- $3.28B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
VKTX Viking Therapeutics, Inc.
- Price
- $26.86 -13.9% · 6M
- Market Cap
- $3.13B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ELVN and VKTX have similar market capitalizations ($3.28B and $3.13B).
- Over the last six months ELVN returned +7.8% and VKTX -13.9%.
- VKTX carries 0.66 times debt per unit of equity, against 0.02 times for ELVN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ELVN | VKTX |
|---|---|---|
| Market Cap | $3.28B | $3.13B |
| P/B Ratio | 3.67x | 5.32x |
| EPS | $-1.83 | $-6.40 |
| Book Value/Share | $12.22 | $5.05 |
| Revenue/Share | – | $0.00 |
| FCF/Share | $-0.91 | – |
Profitability & Margins
| Metric | ELVN | VKTX |
|---|---|---|
| ROE | -11.8% | -106.6% |
| ROA | -11.6% | -64.2% |
| ROIC | -13.9% | -76.9% |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | ELVN | VKTX |
|---|---|---|
| Current Ratio | 64.07x | 7.27x |
| D/E Ratio | 0.02x | 0.66x |
| Financial Leverage | 1.02x | 1.66x |
| Interest Coverage | – | 86.9x |
| Working Capital | $893M | $839M |
Cash Flow
| Metric | ELVN | VKTX |
|---|---|---|
| Operating Cash Flow | -$67M | -$463M |
| Free Cash Flow | -$67M | – |
| Capital Spending | -$100K | – |
Operational Efficiency
| Metric | ELVN | VKTX |
|---|---|---|
| Asset Turnover | – | 0.00x |
Income Statement
| Metric | ELVN | VKTX |
|---|---|---|
| Total Revenue | – | $0.00M |
| Operating Income | -$124M | -$649M |
| Net Income | -$106M | -$627M |
| R&D Expense | $89M | $586M |
Dividend & Shareholder Information
| Metric | ELVN | VKTX |
|---|---|---|
| Shares Outstanding | 73M | 117M |
ELVN vs VKTX: stock comparison and AI forecast
Which is bigger, ELVN or VKTX?
ELVN and VKTX have similar market capitalizations ($3.28B and $3.13B).
Which stock performed better over the last six months, ELVN or VKTX?
Over the last six months ELVN returned +7.8% and VKTX -13.9%.
Which one does Intratio's AI model rank higher, ELVN or VKTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.